Ki-67 expression in pulmonary tumors
- 1 October 2016
- journal article
- editorial
- Published by AME Publishing Company in Translational Lung Cancer Research
- Vol. 5 (5) , 547-551
Abstract
Ki-67 expression in pulmonary tumorsKeywords
This publication has 58 references indexed in Scilit:
- Ki-67 Antigen in Lung Neuroendocrine Tumors: Unraveling a Role in Clinical PracticeJournal of Thoracic Oncology, 2014
- ERCC1 and Ki67 in Small Cell Lung Carcinoma and Other Neuroendocrine Tumors of the Lung: Distribution and Impact on SurvivalJournal of Thoracic Oncology, 2010
- Utility of SKP2 and MIB-1 in grading follicular lymphoma using quantitative imaging analysisHuman Pathology, 2007
- Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysisBritish Journal of Cancer, 2004
- Neuroendocrine Lung Tumors: Grade Correlates with Proliferation but not AngiogenesisLaboratory Investigation, 2001
- Survival Analysis of 200 Pulmonary Neuroendocrine Tumors With Clarification of Criteria for Atypical Carcinoid and Its Separation From Typical CarcinoidAmerican Journal of Surgical Pathology, 1998
- Cranial Computed Tomography as a Part of the Initial Staging Procedures for Patients With Non-Small-Cell Lung CancerChest, 1994
- Cell‐cycle analysis detecting endogenous nuclear antigens: Comparison with BrdU‐in vivolabeling and an application to lung tumorsActa Pathologica Japonica, 1993
- Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies.1990
- Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInternational Journal of Cancer, 1983